Profil
Ken Fyvie currently works at MGB Biopharma Ltd., as Chairman from 2016, Ten Bio Ltd., as Executive Chairman from 2020, and Cytomos Ltd., as Non-Executive Director.
Postes actifs de Ken Fyvie
| Sociétés | Poste | Début |
|---|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology Develops anti-infective medicines | Président | 01/07/2016 |
Cytomos Ltd.
Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Directeur/Membre du Conseil | - |
Ten Bio Ltd.
Ten Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that provides ex vivo skin culture for research and lab testing | Directeur/Membre du Conseil | 01/09/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology Develops anti-infective medicines | Health Technology |
Cytomos Ltd.
Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Commercial Services |
Ten Bio Ltd.
Ten Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that provides ex vivo skin culture for research and lab testing | Commercial Services |
















